News Summary

The Lawson Research Institute at St. Joseph’s Health Care London has been awarded $7.2 million in funding for pioneering research aimed at improving the detection and treatment of Alzheimer’s disease and cancer. This funding supports the development of innovative molecular imaging and theranostics techniques, which combine diagnostics with therapeutics to provide personalized care. The research will focus on neurodegeneration and cancers such as prostate, brain, and breast cancer. Key collaborators include London Health Sciences Centre Research Institute, McMaster University, University Health Network, and BC Cancer. This initiative positions St. Joseph’s as a leader in the field, with the first GE HealthCare Omni Legend 2 PET/CT in Canada and plans for a GE HealthCare Centre of Excellence in Molecular Imaging and Theranostics.